Cover Image


US Newborn Screening Market Outlook 2020

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 354792
出版日期 內容資訊 英文 40 Pages
Back to Top
美國的新生兒篩檢市場預測 US Newborn Screening Market Outlook 2020
出版日期: 2016年03月01日 內容資訊: 英文 40 Pages

美國現在,有93%的嬰兒為了檢驗某種疾病,接受嬰兒用檢查。聯邦政府和州政府也積極進行提高檢驗技術和檢驗普及等支援策略。最許多是血斑檢驗 (乾燥血斑檢驗),接著依序為聽覺檢查,CCDH (先天性、重度的心臟病) 檢驗。嬰兒用篩檢有各種技術手段,尤其是免疫分析法最大量實施。嬰兒用檢查市場,今後由於政府的財政支援和認識度提高,技術進步等,一般認為將成長,不過統一規格、政策的缺乏,及醫院方面的實施體制的延遲,妨礙市場成長。

本報告提供美國國內的新生兒篩檢市場現況與未來展望相關分析,技術的特長和主要的推動及阻礙市場要素,技術、市場趨勢預測 (今後7年份),目前市場動靜、技術水準和今後的方向性,主要企業簡介等相關調查與考察。

第1章 分析師的見解

第2章 分析方法

第3章 新生兒篩檢:概要

第4章 市場推動因素與課題

  • 推動因素
    • 由於政府的輔助策略使知名度上升
    • 嬰兒的染色體異常的增加
    • 由於資金供給支援新生兒篩檢市場成長
  • 課題
    • 由於醫院基礎設施的不足,對新生兒有危險性
    • 法規政策的不透明性

第5章 美國的新生兒篩檢市場概要

第6章 各技術的市場區隔

  • 簡介
    • 酵素、免疫分析法
    • 聽覺篩檢
    • 串聯式質譜分析
    • 脈搏血氧計
    • DNA基礎的檢驗
    • 電泳

第7章 市場趨勢與發展

  • 龐貝氏症的新生兒篩檢的推薦
  • 下一代型定序技術侵入新生兒篩檢市場

第8章 主要企業分析

  • Perkin Elmer
  • Waters Corporation
  • Natus Medical
  • Agilent Technologies Inc.



The US Newborn Screening market is set to witness several developments in near future. In the new report entitled, “US Newborn Screening Market Outlook 2020” the market has been separately studied under tests used for screening, and technologies supporting the diagnosis.

93% of the newborns are screened for various disorders under the newborn screening test in the US. The government is taking various measures to improve the quality and efficiency of these tests. Furthermore, the governments of various states are also engaged in expanding the panel of the tests.

Blood spot test is the most widely performed newborn screening test, followed by hearing screening and Critical Congenital Heart Disease (CCHD) Newborn Screening respectively. The screening technologies used for these tests include tandem mass spectrometry, immunoassays, pulse oximetry, DNA assays and electrophoresis. Immunoassay is the most extensively used technology for newborn screening. The large share of this technology is attributed to the fact that it is a part of primary screening tests for the newborn. Hence, these tests would always witness higher demand.

The report covers developments in the market occurring over the last two years, drivers and challenges controlling the market, and competitive landscape showing prominent players. Factors such as government support through funds, growing awareness, technological advancements and surging genetic disorders are fuelling the growth. On the other hand, lack of uniform regulatory policies in the country and delays in hospital administration are major hurdles of the market.

The study includes prudent analysis of the market size (tests and technologies) for 2014, and forecast till 2020. At the competitive forefront, research has been done at each player including their financials, key products, developments and SWOT analysis. In brief, study presented in the report is likely to generate interest among the potential investors.

Table of Contents

1. Analyst View

2. Research Methodology

3. Newborn Screening - An Introduction

4. Drivers and Challenges

  • 4.1. Drivers
    • 4.1.1. Increased Awareness Due to Government Initiatives
    • 4.1.2. Rising Chromosomal Abnormalities in Infants
    • 4.1.3. Funding Aiding the Growth of Newborn Screening
  • 4.2. Challenges
    • 4.2.1. Lack of Hospital Infrastructure Proving Dangerous for Newborns
    • 4.2.2. Unclear Regulatory Policies

5. US Newborn Screening Market Overview

6. Market Segmentation by Technology

  • 6.1. Introduction
    • 6.1.1. Enzymes and Immunoassays
    • 6.1.2. Hearing Screening
    • 6.1.3. Tandem Mass Spectrometry
    • 6.1.4. Pulse Oximetry
    • 6.1.5. DNA Based Assays
    • 6.1.6. Electrophoresis

7. Trends and Developments

  • 7.1. Newborn Screening Test Recommended for Pompe's Disease
  • 7.2. Next Generation Sequencing Foraying into Newborn Screening

8. Competitive Assessment

  • 8.1. Perkin Elmer
  • 8.2. Waters Corporation
  • 8.3. Natus Medical
  • 8.4. Agilent Technologies Inc.

List of Figures:

  • Figure 5-1: Newborn Screening Test Market (Million US$), 2014 & 2020
  • Figure 5-2: Newborn Screening Technology Market (Million US$), 2014-2020
  • Figure 6-1: US Newborn Screening Market by Technology (%), 2014
  • Figure 6-2: Enzymes and Immunoassays Market for Newborn Screening (Million US$), 2014 & 2020
  • Figure 6-3: Hearing Screen Technology Market for Newborn Screening (Million US$), 2014 &2020
  • Figure 6-4: Tandem Mass Spectrometry Market for Newborn Screening (Million US$), 2014 & 2020
  • Figure 6-5: Pulse Oximetry Technology Market for Newborn Screening (Million US$), 2014 & 2020
  • Figure 6-6: DNA-Based Assays Market for Newborn Screening (Million US$), 2014 & 2020
  • Figure 6-7: Electrophoresis Market for Newborn Screening (Million US$), 2014 & 2020

List of Tables:

  • Table 5-1: Number of Conditions Tested & Cost by States (2014)
  • Table 5-2: Common Misconceptions Held by the Public and the Clinical Facts
  • Table 8-1: Perkin Elmer - Key Financials (Million US$), 2012-2014
  • Table 8-2: Waters Corporation - Key Financials (Million US$), 2012-2014
  • Table 8-3: Natus Medical - Key Financials (Million US$), 2012-2014
  • Table 8-4: Agilent - Key Financials (Million US$), 2013-2015
Back to Top